The Core Value of Cost-Effectiveness Analyses

Journal of the American College of Cardiology

Volumn 67, Issue 1, 2016, Pages 39-41

  Dhruva, Sanket S ^a,b   Krumholz, Harlan M ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

appropriate use; cost benefit analysis; heart valve prosthesis; Key Words aortic stenosis; quality adjusted life years; transcatheter valve therapy

Indexed keywords

AORTA STENOSIS; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DEVICE APPROVAL; EUROPE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LENGTH OF STAY; MEDICARE; MORTALITY; NOTE; PATIENT SAFETY; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; AORTIC VALVE STENOSIS; DEVICES; ECONOMICS; FEMALE; HEART VALVE PROSTHESIS; MALE;

AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84952899545     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.11.013     Document Type: Editorial

References (25)

1. M.B. Leon, C.R. Smith, M. Mack, and et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. C.R. Smith, M.B. Leon, M.J. Mack, and et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
3. U.S. Food and Drug Administration. FDA News Release: FDA approves SAPIEN 3 THV artificial heart valve - Third generation of valve contains design change to minimize leakage. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm451678.htm. Accessed November 3, 2015.
4. J.J. Popma, D.H. Adams, M.J. Reardon, and et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery J Am Coll Cardiol 63 2014 1972 1981
5. M.J. Mack, J. Brennan, R. Brindis, and et al. Outcomes following transcatheter aortic valve replacement in the United States JAMA 310 2013 2069 2077
6. R.L. Osnabrugge, D. Mylotte, S.J. Head, and et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study J Am Coll Cardiol 62 2013 1002 1012
7. R.L. Osnabrugge, A.P. Kappetein, M.R. Reynolds, and D.J. Cohen Cost-effectiveness of transcatheter valvular interventions: economic challenges EuroIntervention 9 Suppl 2013 S48 S54
8. M.R. Reynolds, E.A. Magnuson, Y. Lei, and et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A) J Am Coll Cardiol 60 2012 2683 2692
9. M.R. Reynolds, Y. Lei, K. Wang, and et al. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement J Am Coll Cardiol 67 2016 29 38
10. D.H. Adams, J.J. Popma, M.J. Reardon, and et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
11. M.J. Reardon, D.H. Adams, N.S. Kleiman, and et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement J Am Coll Cardiol 66 2015 113 121
12. S.V. Arnold, M.R. Reynolds, K. Wang, and et al. Health status after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: results from the CoreValve US Pivotal Trial J Am Coll Cardiol Intv 8 2015 1207 1217
13. M.R. Reynolds, E.A. Magnuson, K. Wang, and et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A) J Am Coll Cardiol 60 2012 548 558
14. B.K. Nallamothu, R.A. Hayward, and E.R. Bates Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies Circulation 118 2008 1294 1303
15. S.D. Grosse Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold Expert Rev Pharmacoeconomics Outcomes Res 8 2008 165 178
16. P.J. Neumann, J.T. Cohen, and M.C. Weinstein Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold N Engl J Med 371 2014 796 797
17. A.M. Garber, and C.E. Phelps Economic foundations of cost-effectiveness analysis J Health Economics 16 1997 1 31
18. J.L. Anderson, P.A. Heidenreich, P.G. Barnett, and et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2304 2322
19. S.M. Al-Khatib, A. Hellkamp, J. Curtis, and et al. Non-evidence-based ICD implantations in the United States JAMA 305 2011 43 49
20. N.R. Desai, S.M. Bradley, C.S. Parzynski, and et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention JAMA 314 2015 2045 2053
21. C.A. Jackevicius, J.V. Tu, J.S. Ross, D.T. Ko, and H.M. Krumholz Use of ezetimibe in the United States and Canada N Engl J Med 358 2008 1819 1828
22. K.A. Schulman, S. Balu, and S.D. Reed Specialty pharmaceuticals for hyperlipidemia - impact on insurance premiums N Engl J Med 373 2015 1591 1593
23. R.A. Nishimura, C.M. Otto, R.O. Bonow, and et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 e57 e185
24. T. Taniguchi, T. Morimoto, H. Shiomi, and et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis J Am Coll Cardiol 66 2015 2827 2838
25. J.A. Barreto-Filho, Y. Wang, J.A. Dodson, and et al. Trends in aortic valve replacement for elderly patients in the United States, 1999-2011 JAMA 310 2013 2078 2085